My research focuses on Type 2 Diabetes in youth from a health equity lens. Self-reported racial/ethnic discrimination in healthcare is known to be associated with poor diabetes outcomes and complications. I am currently working with community and provincial partners to understand the lens of access to pediatric Type 2 Diabetes care, including those at high risk for developing Type 2 Diabetes. My research focuses on the impact of family and youth experience in health care, notably self-reported exposure to microaggressions, racial/ethnic discrimination and stigma on diabetes distress, and self-care behaviours.

I am also involved in supporting a number of clinical trials as a co-investigator with Dr. Jean-Pierre Chanoine and Dr. Shazhan Amed for the Division of Endocrinology. These include the (1) X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP), (2) Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients with Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study), (3) A multi-centre follow up study of the effect of in-utero exposure to metformin in 5-11 year old offspring of mothers in the MiTy Trial (MiTy Tykes), (4) Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES) to collect safety and efficacy data in children receiving somatrogon and daily growth hormone.

Other areas of interest include medical education, particularly transition to practice programs for graduating residents, and complex obesity, particularly understanding of clinical care models for management of Prader Willi syndrome.